Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease

Sustained undetectable molecular residual disease (UMRD) is obtained in a minority of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. It remains unclear whether these patients are definitively cured of their leukemia or whether leukemic stem cells (LSCs) persist in th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Chomel, Jean-Claude, Bonnet, Marie-Laure, Sorel, Nathalie, Bertrand, Angelina, Meunier, Marie-Claude, Fichelson, Serge, Melkus, Michael, Bennaceur-Griscelli, Annelise, Guilhot, François, Turhan, Ali G.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2011
Teme:
Myeloid Neoplasia
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5162551/
https://ncbi.nlm.nih.gov/pubmed/21791426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-335497
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki